to study the effect of oxygen supplementation to reduce the surgical wound infections in abdominal surgeries.
Phase 2
- Conditions
- Health Condition 1: C185- Malignant neoplasm of splenic flexure
- Registration Number
- CTRI/2021/02/031436
- Lead Sponsor
- POST GRADUATE INSTITUTE OF MEDICAL COLLEGE AND HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients eligible to give valid consent for the study.
2. Patients undergoing all types of elective major abdominal surgeries including upper gastrointestinal, hepato-pancreato-biliary and lower gastrointestinal like colorectal surgeries.
Exclusion Criteria
1. Immunocompromised patients including poorly controlled diabetes mellitus, patient on long standing steroids.
2. Patient having comorbidities including severe COPD, severe Bronchial Asthma, or any chronic interstitial lung diseases.
3. Patients with any Percutaneous intraabdominal drainage catheter in situ with positive culture report.
4. Patient who receives antibiotic or antiseptic irrigation (IOPL) of the wound or peritoneal cavity during intraoperative period.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO SEE THE REDUCE INCIDENCE OF SURGICAL SITE INFECTIONS IN MAJOR ABDOMINAL SURGERIES.Timepoint: TILL 4 WEEKS
- Secondary Outcome Measures
Name Time Method To see other morbidities; upper respiratory tract infection, urinary tract infection, anastomotic integrity, intensive care unit (ICU) stay, length of Hospital Stay (LoHS) and the need for postoperative interventions including surgery and mortality.Timepoint: TILL 4 WEEKS